0001140361-18-027609.txt : 20180606
0001140361-18-027609.hdr.sgml : 20180606
20180606202651
ACCESSION NUMBER: 0001140361-18-027609
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180430
FILED AS OF DATE: 20180606
DATE AS OF CHANGE: 20180606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FUCHS HENRY J
CENTRAL INDEX KEY: 0001197355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 18885022
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2018-04-30
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001197355
FUCHS HENRY J
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
President, Worldwide R&D
Common Stock
2018-04-30
2018-04-30
4
A
0
309
68.782
A
157101
D
Common Stock
2018-06-04
2018-06-04
4
F
0
1934
92.070
D
155167
D
Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.
Amount of securities beneficially owned has been adjusted from the reporting person's prior report to: a) add 139 shares reported as acquired in the Form 4 Amendment filed with the S.E.C. on 4/26/2018; and b) subtract 23 shares reported as disposed of in the Form 4 Amendment filed with the S.E.C. on 4/27/2018.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2018-06-06